Please ensure Javascript is enabled for purposes of website accessibility
Aerie Pharmaceuticals Stock Quote

Aerie Pharmaceuticals (NASDAQ: AERI)

Price as of ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Aerie Pharmaceuticals Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AERI +48.49% -74.02% -23.61% +44%
S&P -11.99% +53.39% +8.92% +134%

Aerie Pharmaceuticals Company Info

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

News & Analysis

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
407%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 04/01/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.